The biotechnology company Amgen was founded in 1980 as AMGen. With approximately 20,000 employees, Amgen is one of the world's largest biotechnology companies with annual sales of approximately $ 24 billion in 2018.
According to Amgen's latest financial reports the company's total debt is $60.09 Billion USD. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2024-12-31 | $60.09 B | -6.99% |
2023-12-31 | $64.61 B | 65.91% |
2022-12-31 | $38.94 B | 16.92% |
2021-12-31 | $33.30 B | 0.98% |
2020-12-31 | $32.98 B | 10.31% |
2019-12-31 | $29.90 B | -11.87% |
2018-12-31 | $33.92 B | -4% |
2017-12-31 | $35.34 B | 2.16% |
2016-12-31 | $34.59 B | 10.08% |
2015-12-31 | $31.42 B | 2.32% |
2014-12-31 | $30.71 B | -4.4% |
2013-12-31 | $32.12 B | 21.11% |
2012-12-31 | $26.52 B | 23.81% |
2011-12-31 | $21.42 B | 60.37% |
2010-12-31 | $13.36 B | 26.04% |
2009-12-31 | $10.60 B | 4.18% |
2008-12-31 | $10.17 B | -8.96% |
2007-12-31 | $11.17 B | 24.02% |
2006-12-31 | $9.01 B | 127.75% |
2005-12-31 | $3.95 B | -22.56% |
2004-12-31 | $5.11 B | 65.91% |
2003-12-31 | $3.08 B | -2.87% |
2002-12-31 | $3.17 B | 882.04% |
2001-12-31 | $0.32 B | 0.06% |
2000-12-31 | $0.32 B | 0.06% |
1999-12-31 | $0.32 B | -1.89% |
1998-12-31 | $0.32 B | 26.91% |
1997-12-31 | $0.25 B | 46.16% |
1996-12-31 | $0.17 B |